Position in NVS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$7,836,000
+$2,184,250 QoQ
Shares Held
50,000
+35.1% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
1.14%
of 13F equity value
Holder Rank
#199
of 1,603 holders
Holding Since
Mar 2020
18 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Derivatives in NVS
reported options exposure · as of Dec 31, 2020CallValue
$11,331,600
CallShares
120,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026SPHERA FUNDS MANAGEMENT LTD. holds $104,911,681 across 12 Drug Manufacturers - General names. NVS ranks #5 (7.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BIIB |
Biogen Inc.
|
96,626 | $20,877,013 | |
| 2 | AZN |
Astrazeneca PLC
|
62,530 | $11,856,938 | |
| 3 | SNY |
Sanofi
|
269,515 | $11,497,509 | |
| 4 | LLY |
ELI LILLY & Co
|
8,040 | $9,643,418 | |
| 5 | NVS |
Novartis AG
This page
|
50,000 | $7,836,000 | |
| 6 | ABBV |
AbbVie Inc.
|
30,256 | $7,613,619 | |
| 7 | MRK |
Merck & Co., Inc.
|
58,600 | $7,530,100 | |
| 8 | JNJ |
Johnson & Johnson
|
28,831 | $7,322,209 |
All Filings in NVS
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,836,000 | 50,000 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $5,651,750 | 37,000 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $5,101,190 | 37,000 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $4,744,880 | 37,000 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $4,477,370 | 37,000 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $5,574,000 | 50,000 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $4,865,500 | 50,000 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $5,751,000 | 50,000 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $5,323,000 | 50,000 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $4,836,500 | 50,000 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $6,058,200 | 60,000 | Shares | Defined | 2024-02-15 | |
| 2023-09-30 | $6,111,600 | 60,000 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $6,054,600 | 60,000 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $5,520,000 | 60,000 | Shares | Defined | 2023-05-15 | |
| 2020-12-31 | $40,510,470 | 429,000 | Shares | Defined | 2021-02-16 | |
| 2020-12-31 | $11,331,600 | 120,000 | Call | Defined | 2021-02-16 | |
| 2020-09-30 | $24,783,600 | 285,000 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $15,721,200 | 180,000 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $11,543,000 | 140,000 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||